Senotherapeutics

Senotherapeutics research investigates cellular senescence, a state where cells stop dividing and contribute to aging and age-related diseases. This field explores how to selectively eliminate these senescent cells, known as senolytics, or modulate their harmful effects through senomorphics. Researchers employ pharmacological approaches, develop novel drug delivery systems, and utilize advanced imaging techniques to understand the mechanisms driving senescence and its impact on tissue function. Studies also examine the role of extracellular vesicles released by senescent cells and investigate natural compounds with potential senolytic properties.

This research holds relevance for Arkansas by addressing the health challenges associated with an aging population, a demographic trend impacting the state. Developing effective senotherapeutics could improve quality of life and reduce healthcare burdens related to conditions such as arthritis, cardiovascular disease, and neurodegenerative disorders prevalent in the state. Furthermore, exploring natural compounds aligns with Arkansas's agricultural resources, potentially identifying beneficial compounds from local flora.

The work in senotherapeutics is inherently interdisciplinary, drawing upon expertise in pharmacology, cell biology, materials science, and plant physiology. Researchers collaborate across institutions within Arkansas, integrating knowledge from mesenchymal stem cell research, nanoparticle synthesis, and cancer treatment to advance the understanding and application of senotherapeutic strategies.